Healthscore 1022·9 metrosupdated 1h ago

Experimental Alzheimer's Drug Shows Promise in Slowing Cognitive Decline

Researchers have reported that Biogen's experimental drug, diranersen, may slow early Alzheimer's disease by lowering tau protein levels. The findings, presented at the Alzheimer's Association International Conference, suggest potential cognitive benefits comparable to existing amyloid-targeting therapies.

Where it's breaking

DetroitHampton RoadsBaltimoreRichmondLos AngelesPhiladelphiaNew YorkMiami–Ft. LauderdaleBostonLexington, KY

Local coverage

Sources cited

Original outlets that filed on this story across the contributing metros. Click through for the underlying coverage.

What this is

A national rollup is a story Executive Producer detected breaking in multiple US metros at once. Each contributing market has its own deduplicated cluster from local broadcast, print, government, and community sources — this page links them together so a journalist can see the full national footprint. We are a pointer, not a publisher.Every linked headline goes back to the local cluster and from there to the original outlet — that's the URL to cite. A lead, not the law.